Trials / Completed
CompletedNCT00763607
Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC)
Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Radically Resected Non Small Cell Lung Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 454 (actual)
- Sponsor
- Armando Santoro, MD · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Aim of the study is to evaluated the role of IGF1R and p95HER2 on prognosis in radically resected non small cell lung cancer patients The primary objective is to correlate the expression of IGF1R and p95HER2 with survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Protein expression by immunohistochemistry and immunofluorescence | Protein expression by immunohistochemistry and immunofluorescence |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2008-10-01
- Last updated
- 2022-09-10
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00763607. Inclusion in this directory is not an endorsement.